Muir Kevin 4
4 · DELCATH SYSTEMS, INC. · Filed Feb 14, 2024
Insider Transaction Report
Form 4
Muir Kevin
GM INTERVENTIONAL ONCOLOGY
Transactions
- Award
Stock Option (Right to Buy)
2024-02-12+100,500→ 100,500 totalExercise: $4.78Exp: 2034-02-12→ Common Stock (100,500 underlying)
Footnotes (1)
- [F1]The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on February 12, 2024 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended).